Anti-Rat CD45RA (OX-33)
CD45RA Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG1, kappa
Reactivity
rat
Applications
FC
Conjugate
Unconjugated
CloneNo.
OX-33
验证数据展示
经过测试的应用
Positive FC detected in | Wistar rat splenocytes |
推荐稀释比
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
65234-1-Ig targets CD45RA in FC applications and shows reactivity with rat samples.
Tested Applications | FC Application Description |
Tested Reactivity | rat |
Immunogen | Leukocyte common antigen purified from rat splenocytes 种属同源性预测 |
Host / Isotype | Mouse / IgG1, kappa |
Class | Monoclonal |
Type | Antibody |
Full Name | protein tyrosine phosphatase, receptor type, C |
Synonyms | Lca, Ptprc, CD45, RT7, OX-33 |
Calculated Molecular Weight | 143 kDa |
GenBank Accession Number | XM_006249910 |
Gene Symbol | CD45 |
Gene ID (NCBI) | 24699 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Affinity purification |
UNIPROT ID | P04157 |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
背景介绍
CD45, also known as protein tyrosine phosphatase, receptor type C, is a type I transmembrane protein expressed on the surface of all haematopoietic cells with the exception of erythrocytes and platelets (PMID: 3489673; 28615666). CD45 is a pan-haematopoietic cell marker and has been shown to be essential for T- and B-cell activation and signalling (PMID: 9429890; 16378097). CD45 exists as multiple isoforms due to alternative splicing of three exons (4, 5, and 6, designated A, B, and C) in the extracellular domain (PMID: 12414720). CD45RA is expressed on naïve T cells, B cells, and monocytes (PMID: 1830500; 14687231).
实验方案
Product Specific Protocols | |
---|---|
FC protocol for CD45RA antibody 65234-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |